Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny

A technology for intervertebral disc herniation and osteoplasia, applied in capsule delivery, bone disease, drug combination, etc., can solve the problems of ineffective elimination of chemical stimulation, patient drug dependence, and long course of treatment, so as to promote local blood circulation, Effect of promoting metabolic elimination and reducing economic burden

Inactive Publication Date: 2008-06-25
于胜颐
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, in addition to surgery, most of the treatment of this disease is conservative treatment. Among them, pelvic traction and manipulative restoration are the most commonly used basic methods. Although the above methods can effectively reduce mechanical compression, they cannot effectively eliminate chemical stimulation. Relieve local wind-cold-dampness and swelling and congestion pain in the affected area, and the course of treatment is longer
Existing oral medicines, western medicines such as chlorzoxazone, fenbid, indomethacin, etc., mostly focus on pain relief, cannot cure the disease, and patients are prone to drug dependence, long-term use has toxic side effects
However, Chinese patent medicines such as Guci Tablets and Shenjin Dan, etc., have no toxic and side effects, but the therapeutic effect is not very obvious.
Traditional Chinese medicines for external use, such as "Chinese medicinal composition for treating intervertebral disc hyperplasia" in patent No. ZL03142018.4 and "a plaster for treating herniation of intervertebral disc" in patent No. CN200310105386. inconvenient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0009] The composition and weight ratio of the raw materials constituting the active ingredients of the inventive drug-Tongjing capsule are: 1 part of Notopterygium, 2 parts of Duhuo, 2 parts of Clematis, 3 parts of Wujiapi, 2 parts of Pueraria Radix, 3 parts of Aconitum, blood 1 part dried, 2 parts frankincense, 1 part myrrh, 3 parts safflower, 2 parts drynaria, 3 parts Eucommia charcoal, 2 parts white snake, 2 parts earthworm, 1 part ground beetle, 2 parts scorpion, centipede 1 serving.

Embodiment 2

[0011] The composition and weight ratio of the raw materials constituting the active ingredients of the inventive drug-Tongjing Capsule are: 2 parts of Notopterygium, 1 part of Duhuo, 3 parts of Clematis, 2 parts of Radix Wujiapi, 3 parts of Pueraria Radix, 2 parts of Aconitum Aconiti, blood 2 parts of dried fruit, 1 part of frankincense, 2 parts of myrrh, 2 parts of safflower, 3 parts of drynaria, 2 parts of Eucommia charcoal, 3 parts of white snake, 1 part of earthworm, 2 parts of ground beetle, 1 part of scorpion, and centipede 2 servings.

Embodiment 3

[0013] The composition and weight ratio of the raw materials constituting the active ingredients of the inventive drug-Tongjing capsule are: 1 part of Notopterygium, 1 part of Duhuo, 2 parts of Clematis, 2 parts of Radix Wujiapi, 2 parts of Pueraria Radix, 2 parts of Aconitum Aconiti, blood 1.5 parts of dried fruit, 1.5 parts of frankincense, 1.5 parts of myrrh, 2 parts of safflower, 2 parts of drynaria, 2 parts of Eucommia charcoal, 2 parts of white snake, 2 parts of earthworm, 2 parts of ground beetle, 1 part of scorpion, centipede 1 serving.

[0014] Embodiment three is the best embodiment. The preparation methods of the examples are as described above.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a kind of Chinese medicine, named as Tongjing capsule, for treating protrusion of lumbar intervertebral disc and hyperosteogeny. The Chinese medicine is prepared with notopterygium, pubescent angelica root, clematis root, acanthopanax bark, kudzu vine root and other 12 kinds of Chinese medicinal materials. The medicine of the present invention is combined with the application of pelvic traction and hand restitution so as to reach high treating effect.

Description

technical field [0001] The invention relates to a pharmaceutical composition using Chinese herbal medicines as raw materials, in particular to a traditional Chinese medicine capsule for treating intervertebral disc herniation and hyperosteogeny. Background technique [0002] Bone hyperplasia and intervertebral disc herniation are common diseases and frequently-occurring diseases that seriously affect the working ability, and there is a trend of increasing year by year in our country. This disease belongs to the arthralgia category of traditional Chinese medicine. Traditional Chinese medicine believes that wind-cold-damp pathogenic invasion, acute and chronic damage, lead to blockage of meridians, poor flow of qi and blood, and cause disease. . The main symptom of this disease is lumbago and leg pain, and its mechanism of causing lumbago and leg pain is relatively complicated, but it is mainly two aspects of mechanical compression and chemical stimulation. Mechanical compr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/899A61K36/716A61K36/714A61K36/48A61K36/46A61K36/328A61K36/324A61K36/286A61K36/254A61K36/237A61K36/232A61K36/11A61K35/64A61K35/58A61K9/48A61P19/10A61K35/583A61K35/62A61K35/646A61K35/648
Inventor 于胜颐
Owner 于胜颐
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products